| Course | NUR-6400 Advanced Pathophysiology |
|---|---|
| Module | Module 3 |
| Paper type | Case analysis: cardiovascular alteration |
| Length | About 1,066 words, 6 pages |
| Format | APA 7 student paper |
| School | Thomas Edison State University |
| Program | Master of Science in Nursing |
| Updated | October 2026 |
Free sample paper for NUR 6400 Module 3
A Hormone Cut in Two: The Vascular Pathophysiology of Peripartum Cardiomyopathy in a 31-Year-Old Mother of Twins
Student Name
Master of Science in Nursing, Thomas Edison State University
NUR-6400: Advanced Pathophysiology
Mentor Name
Month Day, Year
A Hormone Cut in Two: The Vascular Pathophysiology of Peripartum Cardiomyopathy in a 31-Year-Old Mother of Twins
Introduction
Ms. A. is a composite patient, a 31-year-old office administrator who delivered twins by cesarean section after a pregnancy complicated by preeclampsia. Five weeks later she could not lie flat without coughing, her ankles were swollen by evening and she needed to stop halfway up the stairs. She had put the symptoms down to sleepless nights with two infants. Her echocardiogram found an enlarged, sluggish left ventricle ejecting 30 percent of its volume, with normal valves. Her heart had been normal at a screening visit two years earlier. This paper explains how pregnancy itself can set off a cardiomyopathy and why Ms. A. was at higher risk than most mothers.
Definition and Epidemiology
Sliwa et al. (2010), in a position statement for Europe's cardiology society, set out the definition most papers still use: a weakened left ventricle causing heart failure late in pregnancy or during the first months postpartum, an ejection fraction that is usually under 45 percent, and no other explanation for the failing pump. The ventricle is often, though not always, dilated. Honigberg and Givertz (2019) describe an incidence in the United States of roughly one case per 1,000 to 4,000 live births, with higher rates in women of African ancestry, women with hypertensive disorders of pregnancy, women carrying more than one fetus and older mothers. Ms. A. had three of those four features.
A Pregnancy Hormone Turned Against the Vessels
The best-studied mechanism begins with oxidative stress in the late pregnant and early postpartum heart. Hilfiker-Kleiner et al. (2007) studied mice whose cardiomyocytes lacked the protective transcription factor STAT3 and found that they developed a peripartum heart failure resembling the human disease. In these animals, reactive oxygen species increased the activity of cathepsin D, an enzyme that cuts the 23-kilodalton hormone prolactin into a 16-kilodalton fragment. The fragment, unlike the parent hormone, is antiangiogenic. It damages endothelial cells, causes capillaries in the heart muscle to drop out and impairs the metabolism of the cardiomyocytes those vessels supply. When the researchers blocked prolactin release with bromocriptine, the mice were protected.
Prolactin levels are naturally high after delivery, especially in a mother who is breastfeeding, so the substrate for this harmful fragment is plentiful exactly when the disease appears. That timing is one of the strongest arguments for the mechanism, and it has led to trials of bromocriptine in women with the condition.
The Link With Preeclampsia
A second antiangiogenic signal comes from the placenta. In late pregnancy, and especially in preeclampsia, the placenta releases soluble fms-like tyrosine kinase 1, a decoy receptor that captures vascular endothelial growth factor before it can reach blood vessels. Honigberg and Givertz (2019) describe the overlap between this state and peripartum cardiomyopathy: both involve a shortage of the growth signals that keep small vessels healthy. In a heart already strained by the extra blood volume of pregnancy, and in Ms. A.'s case the larger volume of a twin pregnancy, two antiangiogenic hits arriving together may be more than the microcirculation can withstand.
Genetic Susceptibility
Not every mother exposed to these signals develops cardiomyopathy, so susceptibility must also vary. Some women carry inherited variants in genes for heart muscle proteins, the same variants found in familial dilated cardiomyopathy, and the stress of pregnancy may unmask a heart that was never fully robust (Honigberg & Givertz, 2019). That possibility matters for Ms. A.'s sisters and daughters, and it is one reason family history of cardiomyopathy or unexplained sudden death should be asked about directly. The same reasoning shapes advice about future pregnancies. If the ventricle does not recover fully, another pregnancy brings the same hormonal and hemodynamic load to a heart that has already failed once, and the risk of relapse and death rises; even after recovery, a later pregnancy can bring the weakness back (Honigberg & Givertz, 2019).
From Weak Muscle to Symptoms
Once contractility falls, the familiar heart failure sequence follows. A ventricle that ejects only 30 percent of its volume leaves more blood behind at the end of each beat, which raises filling pressure. The backed-up pressure travels upstream into the lungs, where it forces fluid out of the capillaries; she felt it as breathlessness on effort, and as a night cough when lying down shifted blood from her legs toward her chest. The kidneys sense lower forward flow and activate the renin-angiotensin-aldosterone system, which retains sodium and water and adds to the ankle swelling. The sympathetic nervous system raises heart rate to maintain output, and over time both systems remodel the ventricle further.
These symptoms overlap with the normal discomforts of late pregnancy and new parenthood, which is why diagnosis is often delayed. Ms. A. attributed her breathlessness to fatigue for weeks.
| Finding in Ms. A. | Mechanism |
|---|---|
| Orthopnea and night cough | Raised left-sided filling pressure and pulmonary congestion |
| Ankle swelling by evening | Renal sodium retention from neurohormonal activation |
| Breathless on stairs | Low stroke volume that cannot rise with demand |
| Ejection fraction 30 percent | Loss of contractility after microvascular injury |
Race, Access and Recovery
Women of African ancestry are diagnosed with peripartum cardiomyopathy more often and fare worse. Irizarry et al. (2017) compared Black and non-Black women in a Pennsylvania cohort and found that Black women were diagnosed younger, presented with weaker ventricles, more often worsened after diagnosis and were less likely to recover full function. The reasons are probably several. Genetic differences may play a part, but hypertension in pregnancy is more common among Black women, and differences in access to care, in how seriously early symptoms are taken and in postpartum follow-up can turn a treatable illness into a lasting one. A paper on this disease should hold both explanations without reducing either to the other.
Conclusion
Ms. A.'s heart failure followed a sequence that pregnancy itself set up. Oxidative stress in the heart allowed prolactin to be cut into an antiangiogenic fragment, preeclampsia added a placental signal that starves small vessels, and the heart muscle that depended on those vessels lost its strength. Falling stroke volume and neurohormonal activation then produced the congestion she noticed. Twins, preeclampsia and her ancestry each raised her risk through a step in that chain. The mechanism also explains why treatment includes standard heart failure therapy, why bromocriptine is being studied and why her care should continue well beyond the postpartum visit.
References
Hilfiker-Kleiner, D., Kaminski, K., Podewski, E., Bonda, T., Schaefer, A., Sliwa, K., Forster, O., Quint, A., Landmesser, U., Doerries, C., Luchtefeld, M., Poli, V., Schneider, M. D., Balligand, J.-L., Desjardins, F., Ansari, A., Struman, I., Nguyen, N. Q. N., Zschemisch, N. H., ... Drexler, H. (2007). A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell, 128(3), 589-600. https://doi.org/10.1016/j.cell.2006.12.036
Honigberg, M. C., & Givertz, M. M. (2019). Peripartum cardiomyopathy. BMJ, 364, k5287. https://doi.org/10.1136/bmj.k5287
Irizarry, O. C., Levine, L. D., Lewey, J., Boyer, T., Riis, V., Elovitz, M. A., & Arany, Z. (2017). Comparison of clinical characteristics and outcomes of peripartum cardiomyopathy between African American and non-African American women. JAMA Cardiology, 2(11), 1256-1260. https://doi.org/10.1001/jamacardio.2017.3574
Sliwa, K., Hilfiker-Kleiner, D., Petrie, M. C., Mebazaa, A., Pieske, B., Buchmann, E., Regitz-Zagrosek, V., Schaufelberger, M., Tavazzi, L., van Veldhuisen, D. J., Watkins, H., Shah, A. J., Seferovic, P. M., Elkayam, U., Pankuweit, S., Papp, Z., Mouquet, F., & McMurray, J. J. V. (2010). Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: A position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. European Journal of Heart Failure, 12(8), 767-778. https://doi.org/10.1093/eurjhf/hfq120
What the NUR 6400 Module 3 instructions ask for
Advanced Pathophysiology at TESU lists alterations in body function across the lifespan, and because no syllabus is posted for NUR-6400, this third module takes the cardiovascular system as its focus, as graduate sequences commonly do at this point. A case paper here generally asks you to define the condition precisely, explain its mechanism from cell or vessel to organ, connect the clinical findings to that mechanism and discuss who is at risk and why. Some versions add a pharmacologic link or a comparison with a related disorder. Your mentor's directions decide the case, the length and the source floor, so read them before choosing. A condition with a clear experimental mechanism, such as this one, makes the strongest paper.
How this NUR 6400 Module 3 example is built
A composite mother of twins opens the paper with orthopnea, swelling and an ejection fraction of 30 percent five weeks after delivery. The definition comes from the European heart failure position statement, followed by incidence and risk groups. Two mechanism sections explain the cleaved prolactin fragment found in the STAT3 mouse studies and the placental antiangiogenic signal shared with preeclampsia. A short genetics section raises inherited cardiomyopathy variants. The heart failure sequence then links each symptom to filling pressure or neurohormones, with a four-row table. A section on race uses a Pennsylvania cohort to discuss worse outcomes in Black women, holding biology and access together, and the conclusion ties the chain to treatment.
NUR 6400 Module 3 rubric: what earns full marks
Cardiovascular case papers at the graduate level are marked mostly on whether the mechanism is explained in order and supported by primary evidence. A precise definition from an authoritative source, a mechanism that runs from molecule or vessel to ventricle, and symptoms explained by hemodynamics all count. Risk factors receive credit when they are shown working inside the chain, as preeclampsia does here. Disparities need careful handling: mentors reward papers that use cohort data accurately and avoid treating race as a biological explanation by default. Graduate-level sources, correct terminology such as ejection fraction and filling pressure, and clean APA references complete the work. Linking the mechanism to treatment research shows synthesis.
NUR 6400 Module 3 help from the desk
Many cardiovascular papers spend most of their length on general heart failure physiology that would fit any cause. Keep that part short and spend the words on what is specific to your disease. Another mistake is quoting animal research as if it were proven in humans; say what kind of study found the mechanism. Check definitions, since peripartum cardiomyopathy has a time window and an exclusion rule that students often leave out. When writing about racial differences, report what the study measured and offer more than one explanation. Mentors also notice when a table repeats the text without adding anything. Send the heart case your mentor assigned along with the NUR-6400 directions, and the desk returns a draft shaped to that patient.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official Thomas Edison State University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.
More NUR 6400 and Master of Science in Nursing sample papers
- NUR 6400 Module 1: Cellular Injury Case: Iron Overload in HFE Hemochromatosis
- NUR 6400 Module 2: Immunity Case: Alpha-Gal Syndrome After a Tick Bite
- NUR 6400 Module 4: Fluid and Electrolyte Case: Hyponatremia After a Marathon
- NUR 6400 Module 5: Endocrine Case: Graves Disease and Orbitopathy in a Smoker
- NUR 6400 Module 6: Neurologic Case: Multiple Sclerosis and Epstein-Barr Virus
- NUR 5290 Module 4: Global Health System Comparison
- NUR 6410 Module 1: Pharmacokinetics Case: Apixaban Dosing in an 83-Year-Old Woman
- NUR 5820 Module 6: Business Case
- NUR 5310 Module 6: Informatics Project Proposal
NUR 6400 Module 3 questions, answered
Where can I find a free NUR 6400 Module 3 sample paper?
The paper on this page is complete. It explains peripartum cardiomyopathy in a composite mother of twins, through a cleaved prolactin fragment, preeclampsia and heart failure physiology.
What causes peripartum cardiomyopathy?
The leading mechanism is oxidative stress that lets cathepsin D cleave prolactin into a 16 kDa fragment that damages cardiac blood vessels, combined with antiangiogenic signals from the placenta and, in some women, inherited cardiomyopathy variants.
How is peripartum cardiomyopathy defined?
A weak left ventricle that brings on heart failure in the last weeks of pregnancy or within months of the birth, typically pumping out less than 45 percent of its blood, when nothing else explains it.
Why is preeclampsia a risk factor for peripartum cardiomyopathy?
Preeclampsia raises soluble fms-like tyrosine kinase 1, which blocks vascular growth signals. That adds a second antiangiogenic hit to a heart already exposed to the prolactin fragment.
Who is most at risk of peripartum cardiomyopathy?
Women of African ancestry, women with hypertensive disorders of pregnancy, women carrying twins or more and older mothers. Black women also tend to present with weaker hearts and recover less often.